Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3479)
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$16.60
Total Value
$135.25K
Shares Held After
13,579
% of Holdings
37.5%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
5,537
Price
$223.39
Total Value
$1.24M
Shares Held After
29,603
% of Holdings
15.8%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
500
Price
$3.68
Total Value
$1.84K
Shares Held After
1,385,676
% of Holdings
0.0%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
500
Price
$3.64
Total Value
$1.82K
Shares Held After
1,385,176
% of Holdings
0.0%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
100
Price
$219.00
Total Value
$21.90K
Shares Held After
4,367
% of Holdings
2.3%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,294
Price
$71.38
Total Value
$235.13K
Shares Held After
597,540
% of Holdings
0.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
8,149
Price
$70.50
Total Value
$574.50K
Shares Held After
600,834
% of Holdings
1.3%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
3,557
Price
$69.40
Total Value
$246.86K
Shares Held After
608,983
% of Holdings
0.6%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
3,100
Price
$72.06
Total Value
$223.39K
Shares Held After
97,994
% of Holdings
3.1%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
2,599
Price
$70.77
Total Value
$183.93K
Shares Held After
101,094
% of Holdings
2.5%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,801
Price
$69.75
Total Value
$125.62K
Shares Held After
103,693
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,401
Price
$68.35
Total Value
$369.14K
Shares Held After
767,780
% of Holdings
0.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
12,989
Price
$67.41
Total Value
$875.59K
Shares Held After
773,181
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,610
Price
$66.39
Total Value
$106.88K
Shares Held After
786,170
% of Holdings
0.2%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
12,000
Price
$9.24
Total Value
$110.88K
Shares Held After
180,962
% of Holdings
6.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
828
Price
$439.91
Total Value
$364.25K
Shares Held After
19,959
% of Holdings
4.0%
BeOne Medicines Ltd. (ONC)
Yi Qingqing — Director
Shares
235
Price
$279.13
Total Value
$65.60K
Shares Held After
0
% of Holdings
100.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
3,931
Price
$70.75
Total Value
$278.10K
Shares Held After
8,977
% of Holdings
30.5%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
21,069
Price
$70.11
Total Value
$1.48M
Shares Held After
12,908
% of Holdings
62.0%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
40,000
Price
$70.00
Total Value
$2.80M
Shares Held After
15,257
% of Holdings
72.4%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
2,889
Price
$29.66
Total Value
$85.70K
Shares Held After
793
% of Holdings
78.5%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
1,346
Price
$28.79
Total Value
$38.76K
Shares Held After
3,682
% of Holdings
26.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
1,700
Price
$27.78
Total Value
$47.23K
Shares Held After
5,028
% of Holdings
25.3%
EXELIXIS, INC. (EXEL)
WYSZOMIERSKI JACK L — Director
Shares
3,925
Price
$50.55
Total Value
$198.41K
Shares Held After
284,384
% of Holdings
1.4%
EXELIXIS, INC. (EXEL)
Eckhardt Sue Gail — Director
Shares
9,812
Price
$50.14
Total Value
$491.97K
Shares Held After
16,079
% of Holdings
37.9%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
80,459
Price
$0.47
Total Value
$37.82K
Shares Held After
542,120
% of Holdings
12.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
17
Price
$302.65
Total Value
$5.15K
Shares Held After
1,582
% of Holdings
1.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
495
Price
$300.72
Total Value
$148.86K
Shares Held After
1,599
% of Holdings
23.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
1,222
Price
$299.87
Total Value
$366.44K
Shares Held After
2,094
% of Holdings
36.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
1,175
Price
$298.91
Total Value
$351.22K
Shares Held After
3,316
% of Holdings
26.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
PYOTT DAVID E I — Director
Shares
921
Price
$297.71
Total Value
$274.19K
Shares Held After
4,491
% of Holdings
17.0%
IONIS PHARMACEUTICALS INC (IONS)
BERTHELSEN SPENCER R — Director
Shares
8,000
Price
$75.67
Total Value
$605.36K
Shares Held After
156,013
% of Holdings
4.9%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
6,000
Price
$235.12
Total Value
$1.41M
Shares Held After
372,682
% of Holdings
1.6%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,795
Price
$30.58
Total Value
$54.89K
Shares Held After
34,826
% of Holdings
4.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
1,600
Price
$26.36
Total Value
$42.17K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
13,253
Price
$25.57
Total Value
$338.94K
Shares Held After
1,600
% of Holdings
89.2%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
301
Price
$50.26
Total Value
$15.13K
Shares Held After
158,494
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
1,949
Price
$49.40
Total Value
$96.29K
Shares Held After
158,795
% of Holdings
1.2%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
553
Price
$26.24
Total Value
$14.51K
Shares Held After
27,970
% of Holdings
1.9%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
6,090
Price
$26.20
Total Value
$159.54K
Shares Held After
344,897
% of Holdings
1.7%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
276
Price
$60.87
Total Value
$16.80K
Shares Held After
146,743
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
200
Price
$103.84
Total Value
$20.77K
Shares Held After
85,533
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
279
Price
$101.79
Total Value
$28.40K
Shares Held After
85,733
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,588
Price
$100.65
Total Value
$260.48K
Shares Held After
86,012
% of Holdings
2.9%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,133
Price
$99.86
Total Value
$312.86K
Shares Held After
88,600
% of Holdings
3.4%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
1,200
Price
$98.57
Total Value
$118.28K
Shares Held After
91,733
% of Holdings
1.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
900
Price
$97.68
Total Value
$87.91K
Shares Held After
92,933
% of Holdings
1.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,170
Price
$95.99
Total Value
$208.30K
Shares Held After
93,833
% of Holdings
2.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
960
Price
$94.87
Total Value
$91.08K
Shares Held After
96,003
% of Holdings
1.0%
Liquidia Corp (LQDA)
KIRSCH ARTHUR S — Director
Shares
15,000
Price
$60.22
Total Value
$903.30K
Shares Held After
15,000
% of Holdings
50.0%
Showing 151–200 of 3479 transactions (page 4 of 70)